Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Berlin - Delayed Quote EUR

Oncopeptides AB (OND.BE)

Compare
0.1482
-0.0102
(-6.44%)
At close: April 4 at 7:35:18 PM GMT+2
Loading Chart for OND.BE
  • Previous Close 0.1584
  • Open 0.1578
  • Bid 0.1302 x --
  • Ask 0.1668 x --
  • Day's Range 0.1474 - 0.1594
  • 52 Week Range 0.1128 - 0.4460
  • Volume 0
  • Avg. Volume 18
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: OND.BE

View More

Performance Overview: OND.BE

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

OND.BE
11.09%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

OND.BE
70.54%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

OND.BE
84.18%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

OND.BE
98.40%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: OND.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OND.BE

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    32.53M

  • Enterprise Value

    27.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.43

  • Price/Book (mrq)

    6.24

  • Enterprise Value/Revenue

    9.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: OND.BE

View More

Company Insights: OND.BE

Research Reports: OND.BE

View More